Hualan Biological Engineering
002007.SZ
#3464
Rank
NZ$6.81 B
Marketcap
NZ$3.73
Share price
-1.36%
Change (1 day)
-5.78%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2025 (TTM): NZ$0.32 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are NZ$0.63 Billion. In 2024 the company made an earning of NZ$0.32 Billion a decrease over its 2023 earnings that were of NZ$0.50 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.32 B1.25%
2024 NZ$0.32 B-36.03%
2023 NZ$0.50 B39.14%
2022 NZ$0.36 B-19.27%
2021 NZ$0.45 B-17.84%
2020 NZ$0.54 B37.54%
2019 NZ$0.39 B11.56%
2018 NZ$0.35 B50.74%
2017 NZ$0.23 B1.03%
2016 NZ$0.23 B23.54%
2015 NZ$0.19 B8.4%
2014 NZ$0.17 B10.91%
2013 NZ$0.15 B54.55%
2012 NZ$0.10 B-17.1%
2011 NZ$0.12 B-41.28%
2010 NZ$0.21 B6.13%
2009 NZ$0.19 B261.35%
2008 NZ$54.9 M85.72%
2007 NZ$29.56 M49.33%
2006 NZ$19.79 M56.91%
2005 NZ$12.61 M34.29%
2004 NZ$9.39 M